BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 338492)

  • 1. Anabolic potential of virulent Treponema pallidum.
    Baseman JB; Hayes NS
    Infect Immun; 1977 Dec; 18(3):857-9. PubMed ID: 338492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capacity of virulent Treponema pallidum (Nichols) for deoxyribonucleic acid synthesis.
    Baseman JB; Nichols JC; Mogerley S
    Infect Immun; 1979 Feb; 23(2):392-7. PubMed ID: 370016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of glycosylated protein antigens of Treponema pallidum and Treponema phagedenis.
    Moskophidis M; Müller F
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Jul; 259(4):468-76. PubMed ID: 3901616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cultivation of virulent Treponema pallidum in tissue culture.
    Fieldsteel AH; Cox DL; Moeckli RA
    Infect Immun; 1981 May; 32(2):908-15. PubMed ID: 7019081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cultivation of Treponema pallidum: a review.
    Fitzgerald T
    Bull World Health Organ; 1981; 59(5):787-101. PubMed ID: 6172213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Treponema pallidum antigens: comparison with a nonpathogenic treponeme.
    Lukehart SA; Baker-Zander SA; Gubish ER
    J Immunol; 1982 Aug; 129(2):833-8. PubMed ID: 6177786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The axial filament antigen of Treponema pallidum.
    Penn CW; Bailey MJ; Cockayne A
    Immunology; 1985 Apr; 54(4):635-41. PubMed ID: 3884491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein synthesis by Treponema pallidum extracted from infected rabbit tissue.
    Baseman JB; Hayes NS
    Infect Immun; 1974 Dec; 10(6):1350-5. PubMed ID: 4611927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody with hemagglutination, immobilization, and neutralization activities defines an immunodominant, 47,000 mol wt, surface-exposed immunogen of Treponema pallidum (Nichols).
    Jones SA; Marchitto KS; Miller JN; Norgard MV
    J Exp Med; 1984 Nov; 160(5):1404-20. PubMed ID: 6208310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and localization of integral membrane proteins of virulent Treponema pallidum subsp. pallidum by phase partitioning with the nonionic detergent triton X-114.
    Radolf JD; Chamberlain NR; Clausell A; Norgard MV
    Infect Immun; 1988 Feb; 56(2):490-8. PubMed ID: 3276627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of glycoprotein antigens on surface of Treponema pallidum: comparison with nonpathogenic Treponema phagedenis biotype Reiter.
    Moskophidis M; Müller F
    Infect Immun; 1984 Dec; 46(3):867-9. PubMed ID: 6389370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of fibronectin with Treponema pallidum.
    Fitzgerald TJ; Repesh LA
    Genitourin Med; 1985 Jun; 61(3):147-55. PubMed ID: 3891582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of a Reiter treponemal protein antigen that is immunologically related to an antigen in Treponema pallidum.
    Petersen CS; Pedersen NS; Axelsen NH
    Infect Immun; 1982 Mar; 35(3):974-8. PubMed ID: 6175580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsustained multiplication of treponema pallidum (nichols virulent strain) in vitro in the presence of oxygen.
    Sandok PL; Jenkin HM; Matthews HM; Roberts MS
    Infect Immun; 1978 Feb; 19(2):421-9. PubMed ID: 344209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cultivation of pathogenic Treponema pallidum in vitro.
    Horváth I; Duncan WP; Bullard JC
    Acta Microbiol Acad Sci Hung; 1981; 28(1):7-24. PubMed ID: 7020355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox potential and survival of virulent Treponema pallidum under microaerophilic conditions.
    Steiner B; McLean I; Graves S
    Br J Vener Dis; 1981 Oct; 57(5):295-301. PubMed ID: 7028206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimum concentration of dissolved oxygen for the survival of virulent Treponema pallidum under conditions of low oxidation-reduction potential.
    Graves S; Billington T
    Br J Vener Dis; 1979 Dec; 55(6):387-93. PubMed ID: 393360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the low-molecular-mass proteins of virulent Treponema pallidum.
    Stamm LV; Parrish EA
    Infect Immun; 1994 Jan; 62(1):271-9. PubMed ID: 8262639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of receptor binding proteins and immunogens of virulent Treponema pallidum.
    Baseman JB; Hayes EC
    J Exp Med; 1980 Mar; 151(3):573-86. PubMed ID: 6987326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treponema pallidum does not synthesise in vitro a capsule containing glycosaminoglycans or proteoglycans.
    Strugnell RA; Handley CJ; Lowther DA; Faine S; Graves SR
    Br J Vener Dis; 1984 Feb; 60(1):8-13. PubMed ID: 6365238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.